Litera has acquired AxxiTRIALS clinical trials portal solution that enables secure global document sharing and community management tools for life sciences.
The solution provides life science companies and clinical research organizations (CROs) with a platform for site start-up, patient recruitment, and end-to-end clinical trial operations.
Litera president Karen Massand said, "We see AxxiTRIALS, with its emphasis on outstanding user interface, community building and engagement tools, together with Litera's powerful document lifecycle, security and collaboration solutions as an absolutely unbeatable combination."
Operating efficiency is achieved by AxxiTRIALS as it combines global trial teams from Sponsor, CRO and sites, under a single easy-to-use interface that can engage and integrate with existing systems.
Workflow tools and compliant document management system of AxxiTRIALS speeds the site start-up process, ensures compliance, centralizes key trial information, creates community and keeps investigators and site coordinators engaged throughout the trial.
AxxiTRIALS founder, Litera AxxiTRIALS franchise vice president and general manager Susan Lewenz said, "Interestingly, the CRO clients who have private-labeled our offering tell us that it has even helped them win new business, as many trial sponsors have now witnessed this speed improvement and demand a portal be used for their projects."
Used for trials of all sizes in locations globally, AxxiTRIALS accelerates document handling from feasibility and site start-up documentation, to ongoing safety alert, training and communications management, through the locking of the trial master file.
